Next-Generation Hemostatic System

A futuristic hemostatic system that leverages cutting-edge technologies to revolutionize bleeding control, offering unparalleled efficacy, convenience, and safety.

The original patent's hemostatic composition, comprising an anion exchanger and a calcium salt, has limitations in terms of application, delivery, and biocompatibility. The new inventive concept addresses these limitations by integrating advanced technologies to create a more efficient, user-friendly, and adaptable system for inducing hemostasis.

The next-generation hemostatic system consists of a portable device housing a hemostatic composition, a sensor for detecting bleeding, and a nanocarrier-based delivery system. The system can be worn as a wearable device, featuring a micro-needling system for delivering the composition to the site of bleeding. Alternatively, the composition can be applied through an electrostatically-charged spray nozzle. The hemostatic composition itself comprises an anion exchanger, a calcium salt, and a bio-absorbable polymer matrix, designed to dissolve over time, eliminating the need for removal.

The new claims introduce a paradigm shift in hemostatic technology by integrating advanced delivery systems, sensors, and wearable devices, which are not obvious extensions of the original patent's composition-based approach.

Other embodiments of the inventive concept could include implantable devices, injectable compositions, or even bio-printed matrices. Variations may involve different types of sensors, delivery mechanisms, or bio-absorbable materials.

The next-generation hemostatic system has vast commercial potential in the medical, military, and emergency response industries, offering a game-changing solution for bleeding control and wound management.